Forward Financial Statements From 2010 to 2024
| FWPDelisted Stock | USD 2.56 0.00 0.00% |
Check Forward Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forward main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Forward financial statements analysis is a perfect complement when working with Forward Pharma Valuation or Volatility modules.
Forward |
Forward Pharma A Company Current Valuation Analysis
Forward Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Forward Pharma Current Valuation | (43.04 M) |
Most of Forward Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Forward Pharma A is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Forward Pharma A has a Current Valuation of (43.04 Million). This is 100.3% lower than that of the Biotechnology sector and 100.93% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.26% higher than that of the company.
Forward Pharma A Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Forward Pharma's current stock value. Our valuation model uses many indicators to compare Forward Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Forward Pharma competition to find correlations between indicators driving Forward Pharma's intrinsic value. More Info.Forward Pharma A is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Forward Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Forward Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Forward Pharma's earnings, one of the primary drivers of an investment's value.About Forward Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Forward Pharma income statement, its balance sheet, and the statement of cash flows. Forward Pharma investors use historical funamental indicators, such as Forward Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Forward Pharma investors may use each financial statement separately, they are all related. The changes in Forward Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Forward Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Forward Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Forward Pharma. Please read more on our technical analysis and fundamental analysis pages.
Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma AS was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Forward Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Forward Stock
If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |